These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 2547352)

  • 1. Oral acyclovir reduces the incidence of recurrent herpes simplex keratitis in rabbits after penetrating keratoplasty.
    Beyer CF; Arens MQ; Hill GA; Rose BT; Beyer LR; Schanzlin DJ
    Arch Ophthalmol; 1989 Aug; 107(8):1200-5. PubMed ID: 2547352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Penetrating keratoplasty in rabbits induces latent HSV-1 reactivation when corticosteroids are used.
    Beyer CF; Arens MQ; Hill JM; Rose BT; Hill GA; Lin DT
    Curr Eye Res; 1989 Dec; 8(12):1323-9. PubMed ID: 2560694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The coincidence of HSV-1 ocular cultures with HSV-1 corneal epithelial defects in rabbits after experimental penetrating keratoplasty.
    Portnoy SL; Beyer CF; Hill JM; Kaufman HE
    Cornea; 1991 Jan; 10(1):17-20. PubMed ID: 1850340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral acyclovir after penetrating keratoplasty for herpes simplex keratitis.
    Tambasco FP; Cohen EJ; Nguyen LH; Rapuano CJ; Laibson PR
    Arch Ophthalmol; 1999 Apr; 117(4):445-9. PubMed ID: 10206570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic acyclovir and penetrating keratoplasty for herpes simplex keratitis.
    Foster CS; Barney NP
    Doc Ophthalmol; 1992; 80(4):363-9. PubMed ID: 1473452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative antiviral efficacies of cidofovir, trifluridine, and acyclovir in the HSV-1 rabbit keratitis model.
    Romanowski EG; Bartels SP; Gordon YJ
    Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):378-84. PubMed ID: 9950596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective randomized trial of oral acyclovir after penetrating keratoplasty for herpes simplex keratitis.
    Barney NP; Foster CS
    Cornea; 1994 May; 13(3):232-6. PubMed ID: 8033573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A therapeutic vaccine that reduces recurrent herpes simplex virus type 1 corneal disease.
    Nesburn AB; Burke RL; Ghiasi H; Slanina SM; Wechsler SL
    Invest Ophthalmol Vis Sci; 1998 Jun; 39(7):1163-70. PubMed ID: 9620075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of low-dose and long-term oral acyclovir therapy after penetrating keratoplasty for herpes simplex heratitis.
    Akova YA; Onat M; Duman S
    Ocul Immunol Inflamm; 1999 Mar; 7(1):51-60. PubMed ID: 10410875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Intravenous Acyclovir in Treatment of Herpes Simplex Virus Stromal Keratitis with Ulceration: A Review of 2 Cases.
    Pisitpayat P; Jongkhajornpong P; Lekhanont K; Nonpassopon M
    Am J Case Rep; 2021 Jun; 22():e930467. PubMed ID: 34133412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Acyclovir in herpes simplex corneal ulcers.
    Tormey P; McGill J; Walker C
    Trans Ophthalmol Soc U K (1962); 1981; 101(1):6-8. PubMed ID: 6764319
    [No Abstract]   [Full Text] [Related]  

  • 12. Oral acyclovir for herpes simplex virus eye disease: effect on prevention of epithelial keratitis and stromal keratitis. Herpetic Eye Disease Study Group.
    Arch Ophthalmol; 2000 Aug; 118(8):1030-6. PubMed ID: 10922194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New onset of herpes simplex virus epithelial keratitis after penetrating keratoplasty.
    Rezende RA; Uchoa UB; Raber IM; Rapuano CJ; Laibson PR; Cohen EJ
    Am J Ophthalmol; 2004 Mar; 137(3):415-9. PubMed ID: 15013862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the antiherpetic activity of acyclovir in rabbits.
    Trousdale MD; Nesburn AB
    Am J Med; 1982 Jul; 73(1A):155-60. PubMed ID: 6285707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A controlled trial of oral acyclovir for the prevention of stromal keratitis or iritis in patients with herpes simplex virus epithelial keratitis. The Epithelial Keratitis Trial. The Herpetic Eye Disease Study Group.
    Arch Ophthalmol; 1997 Jun; 115(6):703-12. PubMed ID: 9194719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corneal nerves are necessary for adrenergic reactivation of ocular herpes.
    Rootman DS; Haruta Y; Hill JM; Kaufman HE
    Invest Ophthalmol Vis Sci; 1988 Mar; 29(3):351-6. PubMed ID: 2830200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A primate model for acute and recurrent herpetic keratitis.
    Varnell ED; Kaufman HE; Hill JM; Wolf RH
    Curr Eye Res; 1987 Jan; 6(1):277-9. PubMed ID: 3829703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for herpes simplex virus epithelial keratitis recurring during treatment of stromal keratitis or iridocyclitis. Herpetic Eye Disease Study Group.
    Wilhelmus KR; Dawson CR; Barron BA; Bacchetti P; Gee L; Jones DB; Kaufman HE; Sugar J; Hyndiuk RA; Laibson PR; Stulting RD; Asbell PA
    Br J Ophthalmol; 1996 Nov; 80(11):969-72. PubMed ID: 8976723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of acyclovir on acute and latent herpes simplex virus infections in the rabbit.
    Trousdale MD; Dunkel EC; Nesburn AB
    Invest Ophthalmol Vis Sci; 1980 Nov; 19(11):1336-41. PubMed ID: 7429768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preventive treatment of herpetic keratitis with acyclovir tablets].
    Colin J; Robinet A; Malet F
    J Fr Ophtalmol; 1993; 16(1):6-9. PubMed ID: 8482804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.